Publications

Cardio-Phoenix is proposing a real-world evaluation (RWE) of Cardio-HART, a cardiac diagnostic system, under the NIHR funding competition i4i Challenge.

Using an AI solution to process ECG and novel bio-signals, the CHART algorithms are able to predict structural, functional, and valve abnormalities, effectively reducing this diagnostic gap, thereby allowing for the early detection of most common heart diseases and HF in primary care.

Cardiovascular Disease (CVD) was flagged by the NHS as the most prominent condition in which lives could be saved – with plans of preventing 150,000 heart attacks over a decade. What does the technology look like which can achieve this?

Background Clinical decisions about Heart Failure (HF) are frequently based on measurements of left ventricular ejection fraction (LVEF), relying mainly on echocardiography measurements for evaluating structural and functional abnormalities of heart disease.

Background Echocardiography (ECHO) is not widely available in primary care, the key structural (chamber enlargements) and functional abnormality are not easily available precluding the ability to diagnose HF other than through mainly symptomatic means. The opportunity for earlier detection of HF is lost.

Cardio-HART is the clinician’s AI-powered heart diagnostic assistant. Early detection of heart disease can prolong or increase a patient's quality of life. In addition, it will reduce the burden on the health system and create better communication between GPs and cardiologists.

Cardio-Phoenix recently announced that it received CE Mark approval for its Cardio-Heart heart disease diagnostic device.

CE-marked approval could change the work of specialists and allow them, at the end of the pandemic, to manage the wave of new heart patients.

The great challenge to SARS-CoV-2 virus infection is played out on the ground, through the early identification of new infections and the identification of those at greater risk, such as people with confirmed cardiovascular diseases or risk factors, such as hypertension or obesity.

Ian Bolland caught up with Marc Bisnaire, CEO of Cardio Phoenix to talk about its technology designed to improve the detection of heart disease during and after COVID-19.

An ECG is a test that analyzes the electrical activity of your heart. The test (approx 10 min) involves a technician attaching twelve leads to your chest and then getting a 12-line printout that reflects your heart’s activity during a 10-sec window. So, what does an EKG tell you about your heart’s health?